The Parliamentary Standing Committee on Health and Family Welfare, currently examining the bills to set up the Central Drug Authority and make mandatory the registration of clinical establishments, is thinking of organising another round of visits to some places before finalising its recommendations and submitting it just before the Winter Session of the Parliament by second week of July.

The committee will hold another meeting by the end of this month or early next month to decide on organising still a round of site visits in some other places again to gather views from more people on both the bills under its scrutiny. It is also yet to reach any conclusive views on draft recommendation on any matter related to the bills, sources close to the committee said.

The panel headed by Amar Singh held a sitting here on May 7 in which some NGOs and the representatives of Federation of Indian Chamber of Commerce and Industry made presentations on the formation of the CDA. Without going further into the hearing, sources said it would submit reports on both the bills together as hearings were also being held together.

Sources said it had received lots of suggestions both in support and against the bills, especially on the creation of CDA. ``It is too early to make a comment on the likely recommendations. We will put on record both the supporting and opposing views by the industry and others, and then make our own suggestions going by the majority views,'' sources said, refusing to go further into the details. On inviting technocrat Dr R A Mashelkar, who first recommended CDA, for a hearing, the sources said the invitation was open to all and it would not summon anyone in particular formally.

The committee, examining the Drugs and Cosmetics (amendment) Bill, 2007 and Clinical Establishments Bill, 2007 had already sittings at Bangalore, Thiruvananthapuram, Chennai and Hyderabad in the south. It also visited Indore, Ahmedabad, Mumbai and Goa in the west. For hearing the stakeholders from north and north east states, the committee had sittings in Delhi.

Most of the industry associations who deposed before the panel had vociferously opposed the formation of another centralised authority instead of strengthening the existing mechanism. Stakeholders like Indian Medical Association had also expressed apprehensions on the mandatory registration of clinical establishments in the country.